Division of Cardiology, Department of Medicine, University of Verona, Verona, Italy.
Department of Cardiology, Civil Hospital, Mirano, Venice, Italy -
Minerva Cardiol Angiol. 2021 Oct;69(5):557-578. doi: 10.23736/S2724-5683.20.05391-8. Epub 2020 Nov 4.
The transradial access (TRA) for cardiac catheterization and percutaneous coronary intervention (PCI) has been widely adopted in the last decades since its first description in the late 40s. The transradial approach has been associated with favorable outcomes as compared with transfemoral access (TFA) in several registries and randomized clinical trials, mainly due to the lower incidence of access-site bleedings, vascular complications and improved patient comfort. This review aimed to summarize the body of evidence supporting the use of TRA, to discuss clinical implications, possible technical limitations and future directions, such as the implementation of TRA as the primary access for complex procedures and structural interventions.
经桡动脉入路(TRA)在心脏导管检查和经皮冠状动脉介入治疗(PCI)中的应用已广泛被接受,其最早描述于 40 年代末。多项注册研究和随机临床试验表明,与经股动脉入路(TFA)相比,TRA 具有更好的临床结局,主要是因为 TRA 的血管并发症和出血发生率更低,患者舒适度更高。本综述旨在总结支持 TRA 应用的证据,讨论其临床意义、可能存在的技术局限性以及未来的方向,例如将 TRA 作为复杂手术和结构性介入的首选入路。